In Vitro Hepatic Trans-Differentiation of Human Mesenchymal Stem Cells Using Sera from Congestive/Ischemic Liver during Cardiac Failure

Cellular therapy for end-stage liver failures using human mesenchymal stem cells (hMSCs)-derived hepatocytes is a potential alternative to liver transplantation. Hepatic trans-differentiation of hMSCs is routinely accomplished by induction with commercially available recombinant growth factors, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishi, Dillip Kumar, Mathapati, Santosh, Cherian, Kotturathu Mammen, Guhathakurta, Soma, Verma, Rama Shanker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958528/
https://www.ncbi.nlm.nih.gov/pubmed/24642599
http://dx.doi.org/10.1371/journal.pone.0092397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958528/
https://www.ncbi.nlm.nih.gov/pubmed/24642599
http://dx.doi.org/10.1371/journal.pone.0092397

Ejemplares similares